Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02241720
Title Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Age Groups: adult
Covered Countries USA

No variant requirements are available.